Skip to main content
Ssmartshop.nl
Microdosing risks hero
Honest risk assessment

Microdosing Risks & Side Effects — What You Need to Know

Before microdosing, know the risks. Side effects, drug interactions, who should not microdose, driving rules, and the legal status — all the information you need.

Medical disclaimer included

Possible side effects

Microdosing is generally well-tolerated, but side effects occur in a meaningful minority of users. The most important thing to understand: most side effects are dose-related. If you experience any of the following, the first step is always to reduce your dose or increase the gap between doses. See what users actually report.

Common (10-25% of users)

  • Mild anxiety or unease on dosing days
  • Headache (especially with caffeine combination)
  • Mild nausea within first 30-60 minutes
  • Sleep disturbances if dosed late in the day
  • Heightened emotional sensitivity

Rare (<5% of users)

  • Persistent anxiety that doesn't resolve with dose reduction
  • Visual disturbances (a sign your dose is too high)
  • Worsening of depressive symptoms
  • Difficulty concentrating (paradoxical in some users)
  • Irritability or mood swings

Who should NOT microdose?

Microdosing is not for everyone. The following groups should not microdose without direct medical supervision — and in some cases, should not microdose at all. If you're evaluating whether the potential benefits outweigh the risks for you, read the scientific evidence on benefits first.

SSRI/SNRI users

SSRIs and SNRIs may block or significantly reduce psilocybin effects, and interactions are not fully understood. Do not stop antidepressants abruptly.

Lithium users

Lithium combined with psilocybin has been associated with seizures. This combination must be avoided entirely.

History of psychosis or schizophrenia

Psilocybin can trigger or exacerbate psychotic episodes in people with this history. This is a firm contraindication.

Bipolar disorder (especially type 1)

Risk of triggering manic episodes. Consult a psychiatrist before considering any psychedelic use.

Heart conditions / cardiovascular disease

Psilocybin can mildly increase heart rate and blood pressure. People with serious cardiac conditions should consult a cardiologist.

Pregnancy or breastfeeding

No safety data exists for psilocybin use during pregnancy or breastfeeding. Do not microdose.

Under 18

The adolescent brain is still developing. Psychedelic use before age 18 is not recommended by any researcher in this field.

Drug interactions

Psilocybin interacts with several classes of medications and substances. The most dangerous interactions are with serotonergic drugs, where combining psilocybin can potentially cause serotonin syndrome — a potentially life-threatening condition involving confusion, agitation, rapid heart rate, high blood pressure, dilated pupils, and muscle rigidity.

Drug classRiskRecommendation
SSRIs (Prozac, Zoloft, Lexapro etc.)Blocked or reduced effects; serotonin syndrome risk at high dosesDo not combine without medical supervision
MAOIs (Phenelzine, Tranylcypromine etc.)Serious serotonin syndrome risk — potentially fatalStrictly contraindicated — do not combine
LithiumSeizure risk (documented cases)Do not combine — firm contraindication
Stimulants (Adderall, Ritalin, cocaine)Cardiovascular strain; heightened anxiety; unpredictable effectsAvoid — especially at microdose levels
CannabisAmplified effects; increased anxiety risk; paranoia in susceptible usersUse with caution; avoid on first microdose days

For a complete interaction checker, use our interaction checker tool. If you want to source truffles from trusted sources, our buy guide covers what to look for in a reputable smartshop.

Microdosing & driving

Do not drive on a dosing day. This is not negotiable. Even though microdoses are sub-perceptual, psilocybin is classified as a psychoactive substance under Dutch law (Opiumwet). Driving under the influence of any psychoactive substance is a criminal offense in the Netherlands, with penalties including fines, license suspension, and imprisonment.

The rule of thumb: wait at least 6 hours after taking a microdose before driving. Many experienced practitioners extend this to 8 hours to be safe. If you feel any effects whatsoever — no matter how subtle — do not drive. The risks include not just legal consequences but impaired reaction time and judgment that could endanger yourself and others.

Microdosing & coffee

Coffee is not forbidden during microdosing, but the interaction between caffeine and psilocybin is real and worth managing. Both substances have stimulant properties, and combining them can amplify anxiety, jitteriness, and heart rate elevation — particularly in caffeine-sensitive individuals.

The standard harm-reduction advice: reduce your normal caffeine intake by 50% on dosing days, and wait at least 2-3 hours after your microdose before having your first coffee. If you experience anxiety on dosing days, the caffeine-psilocybin interaction is often the culprit — try eliminating coffee on dosing days entirely before adjusting your truffle dose.

Microdosing & alcohol

Alcohol and psilocybin have opposing effects: psilocybin tends to increase clarity and emotional openness, while alcohol sedates and numbs. Combining them on the same day is not recommended for several reasons: alcohol can blunt psilocybin's benefits, increase nausea, disrupt the emotional processing that microdosing facilitates, and lead to dehydration that worsens the post-dose experience.

The general guidance: avoid alcohol on dosing days. A glass of wine the evening after a morning microdose is generally considered low-risk by experienced practitioners, but heavy drinking should be avoided entirely during active microdosing cycles. Many microdosers report naturally reducing alcohol consumption once they begin microdosing — this appears to be a genuine secondary benefit rather than a deliberate choice.

When to stop microdosing

Stop microdosing and consult a healthcare provider if you experience any of the following warning signs:

  • Persistent anxiety that doesn't improve after reducing the dose
  • Worsening depression or new onset of depressive symptoms
  • Any visual disturbances (potential HPPD risk, though rare)
  • Racing thoughts, pressured speech, or reduced need for sleep (potential hypomania/mania)
  • Increasing dissociation or feeling detached from reality
  • Strong compulsion to increase the dose beyond microdose levels

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Microdosing psychedelic substances carries risks and may interact with medications. Always consult a qualified healthcare professional before starting any microdosing regimen, especially if you have a history of mental health conditions or are taking prescription medications.

Frequently Asked Questions

Can you overdose on a microdose?
Not in the traditional sense — psilocybin has no known lethal dose in humans. However, taking too much on a 'microdosing day' can push you into threshold or mild psychedelic territory, which may be disorienting, anxiety-provoking, or impair your ability to function. This is why precise measurement is critical. If you accidentally take too much, go to a safe, comfortable space, stay calm, and remember it will pass.
Can microdosing cause a 'bad trip'?
At true microdose levels (0.5-1.5g fresh truffles), a full bad trip is not possible because the dose is too small to produce the altered states that characterize a difficult experience. However, some people experience what microdosers call a 'bad microdose day': increased anxiety, irritability, or amplified negative emotions. This is usually dose-related (too high) or context-related (dosing on a high-stress day).
Does microdosing cause tolerance?
Yes, tolerance develops relatively quickly with psilocybin — this is why all protocols include mandatory rest days. Daily use leads to rapid tolerance where effects diminish within days. With the Fadiman Protocol (1 day on, 2 off), tolerance is minimal. With Stamets Stacking (4 on, 3 off), some tolerance may accumulate by the end of the 4-day period. Taking a 2-4 week break between cycles resets tolerance completely.
Is microdosing addictive?
Psilocybin has essentially no addiction potential — it does not activate the dopamine reward pathways that drive compulsive use of addictive substances. Research actually suggests psilocybin may help reduce addiction to other substances (tobacco, alcohol, opioids). Some people develop a psychological habit of wanting to microdose, but this is behaviorally rather than chemically driven and responds well to intentional protocol breaks.
Can I microdose if I'm on SSRIs?
This is strongly discouraged without medical supervision. SSRIs can significantly reduce or completely block psilocybin's effects (because they upregulate 5-HT2A receptors that psilocybin acts on). Some people on SSRIs report no benefit from microdosing at all. Additionally, abruptly stopping SSRIs to try microdosing can cause SSRI discontinuation syndrome and destabilize mental health. Always consult your prescribing doctor.
Does microdosing show up on a drug test?
Standard workplace drug tests do not test for psilocybin or psilocin. However, specialized tests can detect psilocin (the active metabolite of psilocybin) for up to 24 hours after ingestion. If you are subject to drug testing at work, be aware that psilocybin could theoretically show up on an expanded panel test. The safest approach if drug testing is a concern is to not microdose.